You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Tissue Plasminogen Activator

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Acute Respiratory Failure, Hypercoagulability, Fibrinolysis Shutdown Trial in Liverpool (Alteplase)

Recruiting
  • Acute Respiratory Failure
  • +2 more
  • Liverpool, New South Wales, Australia
    Intensive Care Unit, Liverpool Hospital, South Western Sydney Lo
Sep 15, 2022

Pleural Infection Trial in Hong Kong (Tissue Plasminogen Activator)

Not yet recruiting
  • Pleural Infection
  • Tissue Plasminogen Activator
  • Hong Kong, Hong Kong
  • +1 more
Mar 10, 2023

Ocular Trauma Trial in Hangzhou (Tissue Plasminogen Activator)

Recruiting
  • Ocular Trauma
  • Tissue Plasminogen Activator
  • Hangzhou, Zhejiang, China
    Second Affiliated Hospital, School of Medicine, Zhejiang Univers
Feb 20, 2023

Hematoma, Subdural, Fibrinolytic; Hemorrhage Trial in Hamilton (Tissue Plasminogen Activator, Placebo)

Not yet recruiting
  • Hematoma, Subdural
  • Fibrinolytic; Hemorrhage
  • Tissue Plasminogen Activator
  • Placebo
  • Hamilton, Ontario, Canada
    Hamilton General Hospital
Aug 4, 2022

Menstrual Bleeding, Heavy Trial in Portland (Sample Collection and Endometrial Biopsy)

Not yet recruiting
  • Menstrual Bleeding, Heavy
  • Sample Collection and Endometrial Biopsy
  • Portland, Oregon
    OHSU
May 8, 2023

Acute Stroke Trial in Izmir (theory training, theory and simulation training)

Completed
  • Acute Stroke
  • theory training
  • theory and simulation training
  • İzmir, Turkey
    Ozge Soydaner
Jul 15, 2022

Recombinant Tissue Plasminogen Activator Treated Chinese Acute

Completed
  • Stroke
  • Shanghai, China
    Boehringer Ingelheim (China) Investment Co., ltd.
Dec 22, 2022

Acute Ischemic Stroke Trial (IV tPA (Activase))

Not yet recruiting
  • Acute Ischemic Stroke
  • IV tPA (Activase)
  • (no location specified)
Feb 24, 2022

Alteplase in Elderly Acute Ischemic Stroke Patients During

Active, not recruiting
  • Stroke
  • Shanghai, China
    Boehringer Ingelheim (China) Investment Co., ltd.
Jan 9, 2023

Pleural Infection Trial (Intrapleural fibrinolytic with alteplase 5mg and pulmozyme 5 mg, Saline irrigation with 250 mls normal

Not yet recruiting
  • Pleural Infection
  • Intrapleural fibrinolytic with alteplase 5mg and pulmozyme 5 mg
  • Saline irrigation with 250 mls normal saline (over 1 hour)
  • (no location specified)
Jun 19, 2023

Stroke, Acute Ischemic Trial (Tissue Plasminogen Activator (Alteplase))

Not yet recruiting
  • Stroke, Acute Ischemic
  • Tissue Plasminogen Activator (Alteplase)
  • (no location specified)
Aug 16, 2022

Ischemic Stroke, Acute Trial (Recombinant Human tenecteplase Tissue-type Plasminogen Activator (rhTNK-tPA), Best Medical

Not yet recruiting
  • Ischemic Stroke, Acute
  • Recombinant Human tenecteplase Tissue-type Plasminogen Activator (rhTNK-tPA)
  • Best Medical Management
  • (no location specified)
Nov 24, 2022

Tissue Plasminogen Activator Trial in Columbia (early tPA and DNase)

Withdrawn
  • Tissue Plasminogen Activator
  • early tPA and DNase
  • Columbia, South Carolina
    Palmetto Health Richland
Jan 31, 2022

Acute Ischemic Stroke, Arterial Thrombosis, Posterior Circulation Brain Infarction Trial in Beijing (intra-arterial alteplase)

Not yet recruiting
  • Acute Ischemic Stroke
  • +2 more
  • intra-arterial alteplase
  • Beijing, China
    Xuanwu Hospital, Capital Medical University.
Jun 8, 2023

Reduced Dose Thrombolytic in Intermediate/High Risk Pulmonary

Recruiting
  • Pulmonary Embolism
  • Tissue Plasminogen Activator, Alteplase
  • Low-molecular weight heparin
  • İzmir, Bornova/İzmir, Turkey
    Ege University
Aug 22, 2022

Periodontal Diseases, Periodontal Attachment Loss, Periodontal Disease, AVDC Stage 3 Trial in Istanbul (low level laser therapy,

Completed
  • Periodontal Diseases
  • +4 more
  • low level laser therapy
  • non-surgical periodontal treatment
  • Istanbul, Turkey
    Beykent University
Jan 31, 2022

COVID Trial in London (nebulised recombinant tissue-Plasminogen Activator (rt-PA) - Cohort 1, nebulised recombinant

Recruiting
  • COVID
  • nebulised recombinant tissue-Plasminogen Activator (rt-PA) - Cohort 1
  • +2 more
  • London, United Kingdom
  • +1 more
Apr 1, 2021

Stroke, Ischemic Trial in ShenYang (Butyphthalide combined with rtPA, rtPA)

Completed
  • Stroke, Ischemic
  • Butyphthalide combined with rtPA
  • rtPA
  • ShenYang, China
    General Hospital of ShenYang Military Region
Jun 1, 2021

Acute Respiratory Distress Syndrome Trial (Tissue plasminogen activator, Ringer solution)

Withdrawn
  • Acute Respiratory Distress Syndrome
  • Tissue plasminogen activator
  • Ringer solution
  • (no location specified)
Mar 10, 2021

Ischemic Stroke Trial (3K3A-APC, Placebo)

Not yet recruiting
  • Ischemic Stroke
  • 3K3A-APC
  • Placebo
  • (no location specified)
Jul 29, 2022

Stroke, Brain Ischemia Trial in United States (device, drug, procedure)

Recruiting
  • Stroke
  • Brain Ischemia
  • ThermoSuit Cooling Induction
  • +5 more
  • New Orleans, Louisiana
  • +3 more
Jul 12, 2022

Stroke, Ischemic Trial in Shenyang (TNK-Tissue Plasminogen Activator)

Recruiting
  • Stroke, Ischemic
  • TNK-Tissue Plasminogen Activator
  • Shenyang, China
    Department of Neurology, General Hospital of Northern Theater Co
Feb 10, 2022

Eye Diseases, Macular Degeneration, Wet, Sub-Macular Hemorrhage Trial in United Kingdom (Pars plana vitrectomy, Intravitreal 2

Recruiting
  • Eye Diseases
  • +2 more
  • Pars plana vitrectomy
  • +3 more
  • Chelmsford, Essex, United Kingdom
  • +13 more
Aug 2, 2022

Ischemic Stroke, Acute Trial in Spain (Deferoxamine)

Completed
  • Ischemic Stroke, Acute
  • Badalona, Barcelona, Spain
  • +3 more
Aug 4, 2022

Stroke, Acute, Stroke Ischemic Trial in Melbourne (Tenecteplase, Intravenous tissue plasminogen activator (tPA))

Completed
  • Stroke, Acute, Stroke Ischemic
  • Melbourne, Victoria, Australia
  • +4 more
Dec 6, 2021